AnPac Bio-Medical Science Co., Ltd. announced that effective August 2, 2022, the board of directors appointed Jiawen Kang as a member of the board of directors of the Company and a member of the Audit Committee and Nominating Committee. On that date, the Company also appointed Yuyang Cui as Co-Chairman of the Board of the Company. As previously reported, on July 14, 2022, written resolutions were passed by a majority of the votes of all shareholders entitled to vote at a general meeting authorizing, among others, (1) the removal of Aidong Chen and Sheng Liu as members of the Board; (2) the removal of Aidong Chen as Co-Chairman of the Board and Co-Chief Executive Officer of the Company; and (3) the re-designation of Chris Chang Yu as Chief Executive Officer of the Company and Chairman of the Board.